Immune checkpoint inhibitors break whose heart? Perspectives from cardio-immuno-oncology
Immune checkpoint inhibitors (ICIs) are monoclonal antibody antagonists, which can block cytotoxic T lymphocyte antigen-4 (CTLA-4), programmed death-1/ligand-1 (PD-1/PD-L1) pathways, and other molecules exploited by tumor cells to evade T cell-mediated immune response. ICIs have transformed the trea...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
KeAi Communications Co., Ltd.
2024-03-01
|
| Serier: | Genes and Diseases |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S2352304223000478 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
